Lv1
48 积分 2025-11-27 加入
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
1天前
待确认
Cushing's syndrome
9天前
已完结
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
12天前
已完结
PD1 blockade-induced DKK1 expression by CD8+ T cells promotes blood-brain barrier permeabilization
13天前
已完结
TTF-1 expression in lung adenocarcinoma: clinicopathologic, genomic, and immunophenotypic correlates and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
16天前
已完结
Endocrine manifestations of adult malignancy
17天前
已关闭
Encorafenib plus binimetinib versus dabrafenib plus trametinib for the first-line treatment of patients with BRAFV600E-mutant metastatic non-small cell lung cancer: a matching-adjusted indirect treatment comparison
20天前
已关闭
A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (TNBC) (PLANeT trial-Pembrolizumab Low dose in Addition to NACT in TNBC)
25天前
已完结
Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L)1 inhibitor strategies
25天前
已完结
Safety and efficacy of immune checkpoint inhibitors in persons with HIV at a single, tertiary care cancer center in the United States
1个月前
已关闭
皖公网安备34019202002308